EMILIMOGENE SIGULACTIBAC
UNII FBZ2DKU32N

Substance Identification & Data

This profile provides standardized clinical and technical data for Emilimogene Sigulactibac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FBZ2DKU32N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FBZ2DKU32N
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EMILIMOGENE SIGULACTIBAC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12097
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emilimogene Sigulactibac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMILIMOGENE SIGULACTIBAC

Common Names & Synonyms

EMILIMOGENE SIGULACTIBAC [INN]
IPL100
RECOMBINANT LIVE LIMOSILACTOBACILLUS REUTERI BACTERIA (PREVIOUSLY KNOWN AS LACTOBACILLUS REUTERI), STRAIN R2LC, TRANSFORMED WITH A PLASMID EXPRESSING A CODON-OPTIMISED HUMAN C-X-C MOTIF CHEMOKINE LIGAND 12 ISOFORM ALPHA (CXCL12-1.ALPHA.; ALSO KNOWN AS STROMAL CELL-DERIVED FACTOR 1 ISOFORM ALPHA) WITH THE NATIVE SECRETION SIGNAL REPLACED WITH THE SECRETION SIGNAL OF THE L. REUTERI COLLAGEN-BINDING PROTEIN, UNDER CONTROL OF THE INDUCIBLE PROMOTER PORFX (PART OF A PEPTIDE-BASED QUORUM-SENSING SYSTEM)

Technical Codes

ILP-100